SK bioscience Co.,Ltd. (KRX: 302440)
South Korea
· Delayed Price · Currency is KRW
48,800
+800 (1.67%)
Feb 5, 2025, 12:04 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.84 trillion as of February 4, 2025. Its market cap has decreased by -28.57% in one year.
Market Cap
3.84T
Enterprise Value
2.70T
Revenue
201.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
48,800.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.84T, a decrease of -70.31%. That is a compound annual growth rate of -26.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 4, 2025 | 3,760.67B | -4.76% |
Dec 30, 2024 | 3,948.70B | -28.57% |
Dec 28, 2023 | 5,528.45B | -2.04% |
Dec 29, 2022 | 5,643.63B | -67.21% |
Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 76.30T |
Celltrion | 37.63T |
Yuhan | 9,553.80B |
SK Biopharmaceuticals | 8,316.87B |
Hanmi Pharm. | 3,017.89B |
Hanall Biopharma | 2,013.20B |
Hanmi Science | 1,892.60B |
Daewoong Pharmaceutical | 1,593.62B |